Cargando…
Pharmacological c-Jun NH(2)-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice
Spinal muscular atrophy (SMA) is a severe neurodegenerative disorder that occurs in early childhood. The disease is caused by the deletion/mutation of the survival motor neuron 1 (SMN1) gene resulting in progressive skeletal muscle atrophy and paralysis, due to the degeneration of spinal motor neuro...
Autores principales: | Schellino, Roberta, Boido, Marina, Borsello, Tiziana, Vercelli, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131195/ https://www.ncbi.nlm.nih.gov/pubmed/30233310 http://dx.doi.org/10.3389/fnmol.2018.00308 |
Ejemplares similares
-
JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death
por: Schellino, Roberta, et al.
Publicado: (2019) -
c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination
por: Lorenzati, Martina, et al.
Publicado: (2021) -
Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016) -
Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice
por: Boido, Marina, et al.
Publicado: (2023) -
Organotypic spinal cord cultures: An in vitro 3D model to preliminary screen treatments for spinal muscular atrophy
por: Boido, Marina, et al.
Publicado: (2021)